Attention ESSA Pharma Securities Buyers: Important Information Regarding Potential Lawsuit
Investors who purchased securities of ESSA Pharma Inc. (EPIX) between December 12, 2023, and October 31, 2024, are encouraged to take note of an important deadline. The Rosen Law Firm, a leading investor rights law firm, has commenced a class action lawsuit against ESSA Pharma, alleging securities fraud.
What Happened?
According to the complaint, ESSA Pharma made false and/or misleading statements and/or failed to disclose that:
- There were issues with the clinical trial data for its lead product candidate, EPI-5895.
- The data from the clinical trials did not support the efficacy of EPI-5895 for the treatment of acute myeloid leukemia.
- The company had inadequate internal controls over financial reporting.
Impact on Individual Investors
If you purchased ESSA Pharma securities during the Class Period, you may be entitled to compensation through a contingency fee arrangement. The lead plaintiff deadline for this case is March 25, 2025. This means that investors who wish to participate in the lawsuit must file a motion with the court before this deadline in order to be considered as a lead plaintiff. If you are interested in learning more about your potential recovery, you are encouraged to contact The Rosen Law Firm.
Impact on the World
The allegations against ESSA Pharma could have far-reaching implications for the biotech industry as a whole. If the lawsuit is successful, it could serve as a reminder to companies to ensure the accuracy and transparency of their clinical trial data. Moreover, it could encourage investors to be more vigilant when it comes to investing in biotech companies, particularly those with promising but unproven drug candidates.
Conclusion
Investors who purchased ESSA Pharma securities between December 12, 2023, and October 31, 2024, are encouraged to take note of the March 25, 2025 lead plaintiff deadline. If you believe you may be entitled to compensation, it is important to act quickly. The Rosen Law Firm is committed to ensuring that all investors have the opportunity to seek justice and recover their losses. For more information, please contact The Rosen Law Firm.
This information is for informational purposes only and does not constitute legal advice. If you have any questions, please consult with a qualified legal professional.
